| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Revenue | $9.55B | +13.1% |
| R&D Expense | $2.68B | +2.0% |
| SG&A Expense | $912.0M | +11.2% |
| Operating Income | $721.0M | +73.7% |
| Interest Expense | $114.0M | +0.0% |
| Pre-tax Income | $1.01B | +58.2% |
| Income Tax | $316.0M | +182.1% |
| Net Income | $693.0M | +31.7% |
| EPS (Basic) | $2.61 |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.50B | -2.7% |
| Short-term Investments | $3.94B | -39.1% |
| Accounts Receivable | $2.33B | +19.6% |
| Current Assets | $8.43B | -20.1% |
| Total Assets | $18.07B | +0.5% |
| Current Liabilities | $6.38B | +15.0% |
| Long-term Debt | $2.99B | +0.1% |
| Line Item | 2026-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.94B | +19.4% |
| Capital Expenditures | $162.0M | -39.8% |
| Investing Cash Flow | $333.0M | +118.7% |
| Financing Cash Flow | -$3.32B | -188.6% |
| Free Cash Flow | $2.78B | +26.7% |
| +31.8% |
| EPS (Diluted) | $2.59 | +32.8% |
| Total Liabilities |
| $10.27B |
| +14.8% |
| Stockholders' Equity | $7.80B | -13.6% |